CADRENAL THERAPEUTICS, INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of ________, 20__ Debt SecuritiesCadrenal Therapeutics, Inc. • March 12th, 2024 • Pharmaceutical preparations • New York
INDENTURE, dated as of [l], 20[l], among Cadrenal Therapeutics, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
